Product Safety Recalls

Product Recall Tracker

RIFAMPIN Recall D-1343-2022

Description: Rifampin Capsules, USP, 150 mg, 30 count HDPE bottles, Rx Only, Manufactured for Lupin Pharmaceuticals, Inc., Baltimore, MD, 21202 NDC: 68180-658-06

RIFAMPIN Recall D-1343-2022 Information

StatusOngoing
Mandated?Voluntary: Firm initiated
Recall NumberD-1343-2022
Event ID90616
BrandRIFAMPIN
Generic NameRIFAMPIN
ManufacturerRIFAMPIN
Original Package?1
Active SubstanceRIFAMPIN
Drug RouteORAL
DistributionProduct was distributed nationwide.
Quantity7,872/30 count bottles
Recall ReasonCGMP Deviations:OOS result was observed in 1-Methyl-4-Nitroso Piperazine (MNP) impurity.
Drug ClassificationClass II
Drug Code Info20220824
Product NDC68180-658 68180-659
Product NUIN0000175500 M0019113
Drug UPC0368180658061
Pharma Class (EPC)Rifamycin Antibacterial [EPC]
Pharma Class (CS)Rifamycins [CS]
Recall Initiation Date20220728
Report Date20220824
Classification Date20220816
AddressHarborplace Tower111 S Calvert St Fl 21st
Baltimore, MD 21202-6174
United States
Recalling FirmLupin Pharmaceuticals Inc.
Initial Notification Letter
Unique Ingredient IdentifierVJT6J7R4TR
Drug Application NumberANDA090034
Structured Product Labeling (SPL ID)d1ecd7ff-3a5a-46c6-9ca4-71156aa8fbb1
Structured Product Labeling (SPL Set ID)b56004f0-f23d-47f6-80c7-39884fccbccc
Similar To

© 2021 Recall.Report / Contact / Privacy Policy

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied.
Recall.report is not affiliated with the Consumer Product Safety Commision, FDA, or US government in any way.